. Author manuscript; available in PMC: 2021 Jul 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2020 Mar 9;26(7):1266–1272. doi: 10.1016/j.bbmt.2020.02.024

Table 1:

Characteristics of study cohort

	Discovery cohort N = 36	Validation cohort N = 140	P value
Pre-transplant age (years)	13 (8,16)	10 (6,14)	0.7
Male gender	22 (62%)	83 (59%)	0.9
Primary Disease			<0.001
Malignancy	26 (72%)	38 (27%)
Immunodeficiency	4 (11%)	33 (23%)
Bone marrow failure	4 (11%)	65 (46%)
Genetic/metabolic	1 (2 %)	4 (3%)
Benign hematological	1 (2 %)	0 (0%)
Donor			0.24
Unrelated	26 (72%)	93 (66.4%)
Related	10 (28%)	47 (33.6%)
Donor Source			<0.001
Marrow	10 (28%)	102 (72%)
Peripheral blood	26 (72%)	32 (22%)
Cord blood	0 (0%)	1 (1%)
Combined Marrow and Cord	0 (0%)	5 (4%)
Pre-transplant eGFR (ml/min/1.73m²)	134 (107,168)	127 (106,153)	0.15
Myeloablative conditioning	31 (86%)	91 (65%)	<0.001

Data shown as median (inter quartile range) or n (%); eGFR. Estimated glomerular filtration rate